triumeq dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottle
viiv healthcare pty ltd - abacavir sulfate, quantity: 702 mg (equivalent: abacavir, qty 600 mg); lamivudine, quantity: 300 mg; dolutegravir, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; povidone; magnesium stearate; purified water; mannitol; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age who are antiretroviral treatment-na?ve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents (dolutegravir, abacavir or lamivudine) in triumeq.
phebra magnesium sulfate heptahydrate 50% 5g/10ml injection vial
phebra pty ltd - magnesium sulfate heptahydrate, quantity: 500 mg/ml - injection, concentrated - excipient ingredients: water for injections - parenteral administration of magnesium is indicated in the treatment of acute hypomagnesaemia. magnesium salts are also indicated to prevent hypomagnesaemia in patients receiving total parenteral nutrition. magnesium sulphate is also indicated in the prevention and treatment of life-threatening seizures in the treatment of toxemias of pregnancy (pre-eclampsia and eclampsia). for emegency treatment of some arrhythmias such as torsade de pointes and those associated with hypokalemia.
clopidogrel ranbaxy clopidogrel (as hydrogen sulfate) 75 mg tablet blister pack
sun pharma anz pty ltd - clopidogrel hydrogen sulfate, quantity: 97.875 mg (equivalent: clopidogrel, qty 75 mg) - tablet, film coated - excipient ingredients: hydrogenated castor oil; microcrystalline cellulose; lactose monohydrate; macrogol 6000; hyprolose; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.
clopidogrel ran clopidogrel (as hydrogen sulfate) 75 mg tablet blister pack
sun pharma anz pty ltd - clopidogrel hydrogen sulfate, quantity: 97.875 mg (equivalent: clopidogrel, qty 75 mg) - tablet, film coated - excipient ingredients: hydrogenated castor oil; lactose monohydrate; macrogol 6000; microcrystalline cellulose; hyprolose; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease.
quinine sulfate 200mg tablets
alliance healthcare (distribution) ltd - quinine sulfate - oral tablet - 200mg
quinine sulfate 200mg tablets
kent pharma (uk) ltd - quinine sulfate - oral tablet - 200mg
quinine sulfate 200mg tablets
teva uk ltd - quinine sulfate - oral tablet - 200mg
quinine sulfate 200mg tablets
accord-uk ltd - quinine sulfate - oral tablet - 200mg
quinine sulfate 200mg tablets
a a h pharmaceuticals ltd - quinine sulfate - oral tablet - 200mg
aluminium hydroxide 500mg chewable tablets
the boots company plc - aluminium hydroxide dried - chewable tablet - 500mg